Cytokines and chemokines orchestrate atopic skin inflammation

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 1, 2006, Pages 178-189

  Homey, Bernhard ^a   Steinhoff, Martin ^b   Ruzicka, Thomas ^a   Leung, Donald Y M ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Atopic dermatitis; immunity; lymphocyte; pruritus; trafficking

Indexed keywords

CHEMOKINE; CHEMOKINE CCL1; CHEMOKINE CCL18; CHEMOKINE CCL20; CHEMOKINE CCL22; CHEMOKINE CCL26; CHEMOKINE CCL27; CHEMOKINE CCL4; CX3C CHEMOKINE; CYTOKINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 18 BINDING PROTEIN; KININ; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; NEUROPEPTIDE; PROTEINASE; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ATOPY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHIL; HUMAN; IMMUNOLOGY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MEDIATOR; MEMORY T LYMPHOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PRURITUS; REVIEW; SKIN ALLERGY; SKIN INFLAMMATION;

CELL MOVEMENT; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; DERMATITIS, ATOPIC; EOSINOPHILS; HUMANS; IMMUNITY, NATURAL; IMMUNOLOGIC MEMORY; LEUKOCYTES; LYMPHOCYTE ACTIVATION; SKIN;

EID: 33745331786     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.03.047     Document Type: Review

References (83)

1. Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118 (2006) 3-21
2. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T. Neurophysiological, neuroimmunological and neuroendocrine basis of pruritus. J Invest Dermatol. In press 2006.
3. Homey B., Alenius H., Muller A., Soto H., Bowman E.P., Yuan W., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8 (2002) 157-165
4. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
5. Reiss Y., Proudfoot A.E., Power C.A., Campbell J.J., and Butcher E.C. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 194 (2001) 1541-1547
6. Campbell J.J., and Butcher E.C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12 (2000) 336-341
7. Gilliet M., Soumelis V., Watanabe N., Hanabuchi S., Antonenko S., de Waal-Malefyt R., et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 197 (2003) 1059-1063
8. Li M., Messaddeq N., Teletin M., Pasquali J.L., Metzger D., and Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U S A 102 (2005) 14795-14800
9. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203 (2006) 269-273
10. Yoo J., Omori M., Gyarmati D., Zhou B., Aye T., Brewer A., et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202 (2005) 541-549
11. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3 (2002) 673-680
12. Nomura I., Gao B., Boguniewicz M., Darst M.A., Travers J.B., and Leung D.Y. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112 (2003) 1195-1202
13. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
14. Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5 (2004) 752-760
15. Schmelz M. Itch-mediators and mechanisms. J Dermatol Sci 28 (2002) 91-96
16. Steinhoff M., Neisius U., Ikoma A., Fartasch M., Heyer G., Skov P.S., et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23 (2003) 6176-6180
17. Mihara K., Kuratani K., Matsui T., Nakamura M., and Yokota K. Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 151 (2004) 335-345
18. Wood L.C., Jackson S.M., Elias P.M., Grunfeld C., and Feingold K.R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90 (1992) 482-487
19. Wood L.C., Elias P.M., Calhoun C., Tsai J.C., Grunfeld C., and Feingold K.R. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106 (1996) 397-403
20. Matsubara M., Harada D., Manabe H., and Hasegawa K. Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett 566 (2004) 195-200
21. Kanda N., and Watanabe S. Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase C alpha and extracellular signal-regulated kinase in human keratinocytes. J Invest Dermatol 122 (2004) 863-872
22. Konishi H., Tsutsui H., Murakami T., Yumikura-Futatsugi S., Yamanaka K., Tanaka M., et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci U S A 99 (2002) 11340-11345
23. Higa S., Kotani M., Matsumoto M., Fujita A., Hirano T., Suemura M., et al. Administration of anti-interleukin 18 antibody fails to inhibit development of dermatitis in atopic dermatitis-model mice NC/Nga. Br J Dermatol 149 (2003) 39-45
24. Novak N., Kruse S., Potreck J., Maintz L., Jenneck C., Weidinger S., et al. Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 115 (2005) 828-833
25. Butcher E.C., and Picker L.J. Lymphocyte homing and homeostasis. Science 272 (1996) 60-66
26. Homey B., and Zlotnik A. Chemokines in allergy. Curr Opin Immunol 11 (1999) 626-634
27. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
28. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
29. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280 (2005) 35760-35766
30. Gombert M., Dieu-Nosjean M.C., Winterberg F., Bünemann E., Kubitza R.C., Da Cunha L., et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 174 (2005) 5082-5091
31. Kaburagi Y., Shimada Y., Nagaoka T., Hasegawa M., Takehara K., and Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293 (2001) 350-355
32. Gluck J., and Rogala B. Chemokine RANTES in atopic dermatitis. Arch Immunol Ther Exp (Warsz) 47 (1999) 367-372
33. Niwa Y. Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 136 (2000) 125-126
34. Park C.W., Lee B.H., Han H.J., Lee C.H., and Ahn H.K. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Br J Dermatol 152 (2005) 1173-1181
35. Yamada H., Chihara J., Matsukura M., Yasuba H., Yudate T., and Tezuka T. Elevated plasma RANTES levels in patients with atopic dermatitis. J Clin Lab Immunol 48 (1996) 87-91
36. Yawalkar N., Uguccioni M., Scharer J., Braunwalder J., Karlen S., Dewald B., et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113 (1999) 43-48
37. Leung T.F., Wong C.K., Chan I.H., Ip W.K., Lam C.W., and Wong G.W. Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol 110 (2002) 404-409
38. Jahnz-Rozyk K., Targowski T., Paluchowska E., Owczarek W., and Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60 (2005) 685-688
39. Hossny E., Aboul-Magd M., and Bakr S. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 56 (2001) 996-1002
40. Taha R.A., Minshall E.M., Leung D.Y., Boguniewicz M., Luster A., Muro S., et al. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol 105 (2000) 1002-1007
41. Hijnen D., De Bruin-Weller M., Oosting B., Lebre C., De Jong E., Bruijnzeel-Koomen C., et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 113 (2004) 334-340
42. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
43. Lin L., Nonoyama S., Oshiba A., Kabasawa Y., and Mizutani S. TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients. J Med Dent Sci 50 (2003) 27-33
44. Morita E., Hiragun T., Mihara S., Kaneko S., Matsuo H., Zhang Y., et al. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 34 (2004) 237-240
45. Uchida T., Suto H., Ra C., Ogawa H., Kobata T., and Okumura K. Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis. Int Immunol 14 (2002) 1431-1438
46. Pivarcsi A., Gombert M., Dieu-Nosjean M.C., Lauerma A., Kubitza R., Meller S., et al. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J Immunol 173 (2004) 5810-5817
47. Gunther C., Bello-Fernandez C., Kopp T., Kund J., Carballido-Perrig N., Hinteregger S., et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 174 (2005) 1723-1728
48. Nakayama T., Fujisawa R., Yamada H., Horikawa T., Kawasaki H., Hieshima K., et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13 (2001) 95-103
49. Horikawa T., Nakayama T., Hikita I., Yamada H., Fujisawa R., Bito T., et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 14 (2002) 767-773
50. Leung T.F., Ma K.C., Hon K.L., Lam C.W., Wan H., Li C.Y., et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 14 (2003) 296-301
51. Kagami S., Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Nakamura K., et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 134 (2003) 309-313
52. Shimada Y., Takehara K., and Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 34 (2004) 201-208
53. Hon K.L., Leung T.F., Ma K.C., Li A.M., Wong Y., and Fok T.F. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children. Clin Exp Dermatol 29 (2004) 293-296
54. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 127 (2002) 270-273
55. Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Asano N., Mitsui H., et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 111 (2003) 592-597
56. Echigo T., Hasegawa M., Shimada Y., Takehara K., and Sato S. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 113 (2004) 940-948
57. Ruzicka T., Bieber T., Schopf E., Rubins A., Dobozy A., Bos J.D., et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 337 (1997) 816-821
58. Woodward A.L., Spergel J.M., Alenius H., Mizoguchi E., Bhan A.K., Castigli E., et al. An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis. J Allergy Clin Immunol 107 (2001) 359-366
59. Morales J., Homey B., Vicari A.P., Hudak S., Oldham E., Hedrick J., et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A 96 (1999) 14470-14475
60. Homey B., Wang W., Soto H., Buchanan M.E., Wiesenborn A., Catron D., et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164 (2000) 3465-3470
61. Bruna-Romero O., Schmieg J., Del Val M., Buschle M., and Tsuji M. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria. J Immunol 170 (2003) 3195-3203
62. Caux C., Ait-Yahia S., Chemin K., de Bouteiller O., Dieu-Nosjean M.C., Homey B., et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22 (2000) 345-369
63. Koch S., Kohl K., Klein E., von Bubnoff D., and Bieber T. Skin homing of Langerhans cell precursors: adhesion, chemotaxis, and migration. J Allergy Clin Immunol 117 (2006) 163-168
64. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 (1998) 373-386
65. Vanbervliet B., Homey B., Durand I., Massacrier C., Ait-Yahia S., de Bouteiller O., et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 32 (2002) 231-242
66. Ma W., Bryce P.J., Humbles A.A., Laouini D., Yalcindag A., Alenius H., et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109 (2002) 621-628
67. Grewe M., Gyufko K., Schopf E., and Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 343 (1994) 25-26
68. Grewe M., Walther S., Gyufko K., Czech W., Schopf E., and Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105 (1995) 407-410
69. Grewe M., Bruijnzeel-Koomen C.A., Schopf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19 (1998) 359-361
70. Ying S., O'Connor B., Ratoff J., Meng Q., Mallett K., Cousins D., et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 174 (2005) 8183-8190
71. Al-Shami A., Spolski R., Kelly J., Keane-Myers A., and Leonard W.J. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 202 (2005) 829-839
72. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
73. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276 (2001) 5707-5713
74. Schibli D.J., Hunter H.N., Aseyev V., Starner T.D., Wiencek J.M., McCray Jr. P.B., et al. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277 (2002) 8279-8289
75. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171 (2003) 3262-3269
76. Twycross R., Greaves M.W., Handwerker H., Jones E.A., Libretto S.E., Szepietowski J.C., et al. Itch: scratching more than the surface. QJM 96 (2003) 7-26
77. Schmelz M., Schmidt R., Bickel A., Handwerker H.O., and Torebjork H.E. Specific C-receptors for itch in human skin. J Neurosci 17 (1997) 8003-8008
78. Schmelz M. A neural pathway for itch. Nat Neurosci 4 (2001) 9-10
79. Urashima R., and Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch 432 (1998) 363-370
80. Diveu C., Lak-Hal A.H., Froger J., Ravon E., Grimaud L., Barbier F., et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur Cytokine Netw 15 (2004) 291-302
81. Bilsborough J., Leung D.Y., Maurer M., Howell M., Boguniewcz M., Yao L., et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 117 (2006) 418-425
82. Sonkoly E., Muller A., Lauerma A.I., Pivarcsi A., Soto H., Kemeny L., et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117 (2006) 411-417
83. Paus R., Schmelz M., Biro T., and Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116 (2006) 1174-1186